Brief History of Important Immunologic Discoveries and Developments
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Alfred Nobel
www.bibalex.org/bioalex2004conf The BioVisionAlexandria 2004 Conference Newsletter November 2003 Volume 1, Issue 2 BioVisionAlexandria ALFRED NOBEL 2004 aims to celebrate the The inventor, the industrialist outstanding scientists and scholars, in a he Nobel Prize is one of the highest distinctions recognized, granting its winner century dominated by instant fame. However, many do not know the interesting history and background technological and T that led to this award. scientific revolutions, through its It all began with a chemist, known as Alfred Nobel, born in Stockholm, Sweden in 1833. Nobel Day on 3 April Alfred Nobel moved to Russia when he was eight, where his father, Immanuel Nobel, 2004! started a successful mechanical workshop. He provided equipment for the Russian Army and designed naval mines, which effectively prevented the British Royal Navy from moving within firing range of St. Petersburg during the Crimean War. Immanuel Nobel was also a pioneer in the manufacture of arms, and in designing steam engines. INSIDE Scientific awards .........3 Immanuel’s success enabled him to Alfred met Ascanio Sobrero, the Italian Confirmed laureates ....4 Lady laureates ............7 provide his four sons with an excellent chemist who had invented Nitroglycerine education in natural sciences, languages three years earlier. Nitroglycerine, a and literature. Alfred, at an early age, highly explosive liquid, was produced by acquired extensive literary knowledge, mixing glycerine with sulfuric and nitric mastering many foreign languages. His acid. It was an invention that triggered a Nobel Day is interest in science, especially chemistry, fascination in the young scientist for many dedicated to many of was also apparent. -
Primer the Complement System
View metadata, citation and similar papers at core.ac.uk brought to you by CORE providedMagazine by ElsevierR259 - Publisher Connector vascular permeability and the infection. The second category Primer extravasation of plasma. This is in which there is persistent accompanied by the adhesion of formation of immune complexes is leukocytes to vascular endothelium autoimmune disease, in which, by The complement and their emigration into definition, the antigen is a system surrounding tissue. Complement permanent feature of the host. plays an important part in An understanding of how immune Philip Taylor, Marina inflammation, in helping to recruit complexes cause tissue injury effector cells and in promoting the developed from study of such Botto and Mark Walport killing and clearance of pathogens. diseases in humans and animals, and But complement can be both from the induction of experimental The system of plasma proteins called friend and foe. In some immune complex disease. In these complement was so-named because circumstances the activation of situations, immune complexes were it complements the activity of complement in response to immune shown to cause tissue injury through antibody in the lysis of bacteria. It complexes may cause harm: acutely activation of complement, as opsonin has a central role in host defence in the context of massive (binding to complement receptors on against many micro-organisms and in complement activation occurring in leukocytes) and as the source of the modulation of inflammatory patients with overwhelming Gram- anaphylatoxins (stimulating leukocyte reactions, an activity that has been negative bacterial sepsis, and chemotaxis and degranulation). But illuminated by the study of humans chronically, when an antibody the development of gene-targeted with naturally occurring deficiencies response develops in the context of mice with deficiencies of complement of complement. -
Meduni Wien Imagebroschuere
We shape the future Key numbers IN THE TOP 100 worldwide in the medicine category of leading university rankings 8,000 students outpatient treatments annually at Vienna General Hospital 5,750 employees operations annually, including 750 transplants Doing everything to support health Founded in 1365 as the medical faculty of the University of Vienna and made an independent university in 2004, today MedUni Vienna is among Europe’s most highly respected centres of medical training and research. 2 Focused programmes of study MedUni Vienna has an educational offering that ranges from undergraduate degrees to continuing education courses and PhD programmes. MEDICINE DEGREE DENTISTRY DEGREE PROGRAMME PROGRAMME MEDICAL INFORMATICS PHD PROGRAMMES MASTER’S PROGRAMME POSTGRADUATE APPLIED MEDICAL CONTINUING SCIENCE DOCTORAL EDUCATION COURSES PROGRAMME AND CERTIFICATE COURSES Measurable success Since its establishment as an independent university in 2004, research output has grown at MedUni Vienna. This can be seen in the university’s consistent upward progress in significant rankings including the US News Best Global Universities Rankings and the QS World University Rankings. 3 Gerard van Swieten Carl von Rokitansky Josef Skoda Ignaz Philipp Semmelweis Karl Landsteiner Róbert Bárány 4 City of Medicine Medical pioneers: the Vienna School of Medicine Modern medicine was born in the theories of Ignaz Philipp Jewish heritage or dissident Vienna. Gerard van Swieten, Semmelweis in clinical practice thinkers, and were murdered, personal physician to Empress for the first time anywhere in expelled or forced to flee by Maria Theresa, introduced bed- the world. In the 20th century, the National Socialist regime side teaching into medical edu- Karl Landsteiner and Róbert – among them Sigmund Freud, cation in the 18th century. -
FORMATO PDF Ranking Instituciones No Acadã©Micas Por Sub Ã
Ranking Instituciones No Académicas por sub área OCDE 2020 3. Ciencias Médicas y de la Salud > 3.02 Medicina Clínica PAÍS INSTITUCIÓN RANKING PUNTAJE USA VA Boston Healthcare System 1 5,000 FRANCE Assistance Publique Hopitaux Paris (APHP) 2 5,000 USA UTMD Anderson Cancer Center 3 5,000 USA Mayo Clinic 4 5,000 USA Memorial Sloan Kettering Cancer Center 5 5,000 USA Dana-Farber Cancer Institute 6 5,000 USA Massachusetts General Hospital 7 5,000 FRANCE Institut National de la Sante et de la Recherche Medicale (Inserm) 8 5,000 USA National Institutes of Health (NIH) - USA 9 5,000 FRANCE UNICANCER 10 5,000 USA Harvard School of Dental Medicine 11 5,000 CANADA University Health Network Toronto 12 5,000 USA Cleveland Clinic Foundation 13 5,000 USA Johns Hopkins Medicine 14 5,000 FRANCE Gustave Roussy 15 5,000 NETHERLANDS Erasmus University Medical Center 16 5,000 GERMANY Helmholtz Association 17 5,000 NETHERLANDS Academic Medical Center Amsterdam 18 5,000 SPAIN CIBER - Centro de Investigacion Biomedica en Red 19 5,000 USA Beth Israel Deaconess Medical Center 20 5,000 SWITZERLAND Roche Holding 21 5,000 CANADA Princess Margaret Cancer Centre 22 5,000 USA H Lee Moffitt Cancer Center & Research Institute 23 5,000 SPAIN Hospital Universitari Vall d'Hebron 24 5,000 BELGIUM University Hospital Leuven 25 5,000 USA NIH National Cancer Institute (NCI) 26 5,000 SPAIN Hospital Clinic de Barcelona 27 5,000 USA Bristol-Myers Squibb 28 5,000 USA Merck & Company 29 5,000 UNITED KINGDOM Royal Marsden NHS Foundation Trust 30 5,000 SOUTH KOREA Seoul National University -
Foundation Block Lecture Three Cell Mediated Immunity
Foundation Block Lecture Five Hypersensitivity Objectives: • To know that hypersensitivity reactions are over and excessive immune responses that can be harmful to body in four different ways • To be familiar with inflammatory processes in type I hypersensitivity reaction that mediates allergic inflammation • To recognize that type II hypersensitivity deals with immune responses against antigens that are integral part of cell membrane and are usually associated with autoimmune disorders • To know that type III hypersensitivity reactions are mediated by immune complexes and cause vasculitis • To describe type IV hypersensitivity is a purely cell mediated immune response associated with chronic inflammation ● Important. ● Extra notes. ● Females notes ● Males notes. What is hypersensitivity? Protective immunity: desirable reaction. Hypersensitivity: undesirable damaging reaction produced by excessive immune reactions. - Undesirable responses can be mediated by: - Antibody binding to antigens (Types I-III). - Cell mediated reaction to chemicals or proteins (Type IV). Types of hypersensitivity: 4 Types of hypersensitivity responses are classified by GEL AND COOMBS (names of scientists) according to the responding mechanisms, NOT the responding antigens: *From 433 team Type I: 1- Also termed as: - Immediate Hypersensitivity. - Allergic reactions. (e.g. asthma and eczema) - Anaphylactic reactions: severe and rapidly progressing systemic forms which can be quickly life threatening. …..............(causes.vasodilation and hypovolemia which causes heart stop then death) 2- Most people will not react to these allergens but some individuals “atopic” respond by producing large amounts of IgE in …........response to those otherwise harmless substances. 3- Non-allergic individuals respond to these allergens by producing IgG antibodies. 4- Features: - Antibody type: IgE - Cellular components: Mast cells, basophiles & eosinophils - Antigens: Also known as allergens ( antigens with low molecular weight & highly soluble). -
NIH Public Access Author Manuscript Nat Genet
NIH Public Access Author Manuscript Nat Genet. Author manuscript; available in PMC 2013 October 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Nat Genet. 2013 April ; 45(4): 371–384e2. doi:10.1038/ng.2566. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Stig E Bojesen1,2,*, Karen A Pooley3,*, Sharon E Johnatty4,*, Jonathan Beesley4,*, Kyriaki Michailidou3,*, Jonathan P Tyrer5,*, Stacey L Edwards6, Hilda A Pickett7,8, Howard C Shen9, Chanel E Smart10, Kristine M Hillman6, Phuong L Mai11, Kate Lawrenson9, Michael D Stutz7,8, Yi Lu4, Rod Karevan9, Nicholas Woods12, Rebecca L Johnston10, Juliet D French6, Xiaoqing Chen4, Maren Weischer1,2, Sune F Nielsen1,2, Melanie J Maranian5, Maya Ghoussaini5, Shahana Ahmed5, Caroline Baynes5, Manjeet K Bolla3, Qin Wang3, Joe Dennis3, Lesley McGuffog3, Daniel Barrowdale3, Andrew Lee3, Sue Healey4, Michael Lush3, Daniel C Tessier13,14, Daniel Vincent13,14, Françis Bacot13,14, Study Group members15, Ignace Vergote16,17, Sandrina Lambrechts16,17, Evelyn Despierre16,17, Harvey A Risch18, Anna González-Neira19, Mary Anne Rossing20,21, Guillermo Pita19, Jennifer A Doherty22, Nuria Álvarez19, Melissa C Larson23, Brooke L Fridley23, Nils Schoof24, Jenny Chang- Claude25, Mine S Cicek26, Julian Peto27, Kimberly R Kalli28, Annegien Broeks29, Sebastian M Armasu23, Marjanka K Schmidt29,30, Linde M Braaf29, Boris Winterhoff31, Heli Nevanlinna32, Gottfried E Konecny33, Diether Lambrechts34,35, -
Medicine Merit Badge Requirements
Columbia-Montour Council MEDICINE NOTES FOR SCOUTS: LIMITED TO 20 SCOUTS 1. Scouts are required to obtain the Medicine merit badge book, study its contents and be prepared to discuss all requirements with the counselor. 2. All items listed in bold type are prerequisites that MUST be completed prior to the event and emailed to your counselor at least 2 weeks before MBC. 3. Scouts are required to download and use the Workbook, and have all requirements filled out before they arrive the day of the event, which may be downloaded at http://www.MeritBadge.org . 4. Counselor: Ralph Baker 570-271-1049, [email protected] Medicine merit badge requirements 1. Discuss with your counselor the influence that EIGHT of the following people or events had on the history of medicine: a. Hippocrates b. William Harvey c. Antoine van Leeuwenhoek d. Edward Jenner e. Florence Nightingale f. Louis Pasteur g. Gregor Mendel h. Joseph Lister i. Robert Koch j. Daniel Hale Williams k. Wilhelm Conrad Roentgen l. Marie and Pierre Curie m. Walter Reed n. Karl Landsteiner o. Alexander Fleming p. Charles Richard Drew q. Helen Taussig r. James Watson and Francis Crick s. Jonas Salk 2. Explain the Hippocratic Oath to your counselor, and compare to the original version to a more modern one. Discuss to whom those subscribing to the original version of the oath owe the greatest allegiance. 3. Discuss the health-care provider-patient relationship with your counselor, and the importance of such a relationship in the delivery of quality care to the patient. Describe the role of confidentiality in this relationship. -
Development and Evaluation of a Simple Latex Agglutination Test for Diagnosis of Tuberculosis' R
APPuED MICROBIOLOGY, Oct. 1972, p. 525-534 Vol. 24, No. 4 Copyright 0 1972 American Society for Microbiology Printed in U.S.A. Development and Evaluation of a Simple Latex Agglutination Test for Diagnosis of Tuberculosis' R. V. COLE,2 A. W. LAZARUS, AND H. G. HEDRICK Department of Botany and Bacteriology, College of Life Sciences, Louisiana Tech University, Ruston, Louisiana 71270 Received for publication 1 March 1972 A simple latex agglutination test (SLAT) based on modifications of existing serodiagnostic techniques, in which commercially available reagents are used, was developed for detection of antibodies against Mycobacterium tuberculosis. Tests performed on 553 serum samples from 316 individuals, including 117 bacteriologically confirmed active tuberculosis patients, showed 80% positive titers. Sera from 12 patients with arrested tuberculosis showed 91% positive titers. Nonspecific reactions were noted in 5% of 160 serums from selected normal individuals and patients with diseases other than tuberculosis. The an- tibodies detected by the SLAT method were found to be relatively stable when exposed to low temperatures, whereas high temperatures reduced the antibody titer considerably. Disodium ethylenediaminetetraacetic acid inactivation of serum complement was found to be satisfactory. No variation of tuberculosis antibody titer was noted in tests on multiple specimens from patients whose conditions were stabilized. However, considerable fluctuation was encountered in antibody titers obtained on recently detected individuals. Data obtained in this study indicate that the modified procedures of the SLAT method could replace the tuberculin skin test for simple screening of tuberculosis in adults. The use of tuberculin skin test procedures of serodiagnostic methods for the detection of has been the basis for the detection of new tuberculosis antibodies. -
DMJ.1936.2.1.A02.Young.Pdf (3.644Mb)
DALHOUSIE MEDICAL JOURNAL 5 A Memorable Conference THE HARVARD TERCENTENARY 1636 - 1936 E. GORDON YOUNG, B.A., M.Sc., Ph.D., F.R.S.C. OMEONE has said that the most valuable and rarest thing in the world S is a new idea. It is the verdict or the intellectual world of science, of art and of music that progress centres largely about the thoughts ex pressed by the few great minds of the centuries. The work of the scientists of the world has been likened to a great canvas, the subject of which has been chosen by the few and the first bold lines inserted, but the great mass of colour and detail has been supplied by the many faithful apprentices. It was most fitting that the oldest and greatest of American Universities should celebrate its three hundredth birthday in an intellec tual feast and that it should invite to its table as leaders of conversation the greatest minds of the world in those subjects which were proposed for discussion. Harvard.!J.as a magnificent record of intellectual tolerance and its hospitality was open to individuals of all nationalities and all re- ligious and political creeds. To Cambridge thus in the early days of September, 1936, there came, by invitation, a group of about two thousand five hundred American and Canadian scholars to participate in a memorable series of symposia led by a special group of sixty-seven eminent scientists and men of letters from fifteen different countries. These included no fewer than eleven men who had the greatest single distinction in the realms of science and of letters, the Nobel Prize. -
Citrullinated Protein Antibody Paratope Drives Epitope Spreading and Polyreactivity in Rheumatoid Arthritis
Arthritis & Rheumatology Vol. 0, No. 0, Month 2019, pp 1–11 DOI 10.1002/art.40760 © 2019, American College of Rheumatology Affinity Maturation of the Anti–Citrullinated Protein Antibody Paratope Drives Epitope Spreading and Polyreactivity in Rheumatoid Arthritis Sarah Kongpachith, Nithya Lingampalli, Chia-Hsin Ju, Lisa K. Blum, Daniel R. Lu, Serra E. Elliott, Rong Mao and William H. Robinson Objective. Anti–citrullinated protein antibodies (ACPAs) are a hallmark of rheumatoid arthritis (RA). While epitope spreading of the serum ACPA response is believed to contribute to RA pathogenesis, little is understood regarding how this phenomenon occurs. This study was undertaken to analyze the antibody repertoires of individuals with RA to gain insight into the mechanisms leading to epitope spreading of the serum ACPA response in RA. Methods. Plasmablasts from the blood of 6 RA patients were stained with citrullinated peptide tetramers to identify ACPA- producing B cells by flow cytometry. Plasmablasts were single-cell sorted and sequenced to obtain antibody repertoires. Sixty-nine antibodies were recombinantly expressed, and their anticitrulline reactivities were characterized using a cyclic citrullinated peptide enzyme- linked immuosorbent assay and synovial antigen arrays. Thirty- six mutated antibodies designed either to represent ancestral antibodies or to test paratope residues critical for binding, as determined from molecular modeling studies, were also tested for anticitrulline reactivities. Results. Clonally related monoclonal ACPAs and their shared ancestral antibodies each exhibited differential re- activity against citrullinated antigens. Molecular modeling identified residues within the complementarity-determining region loops and framework regions predicted to be important for citrullinated antigen binding. Affinity maturation re- sulted in mutations of these key residues, which conferred binding to different citrullinated epitopes and/or increased polyreactivity to citrullinated epitopes. -
New Aspects of Human Trichinellosis: the Impact of New Trichinella Species F Bruschi, K D Murrell
15 REVIEW Postgrad Med J: first published as 10.1136/pmj.78.915.15 on 1 January 2002. Downloaded from New aspects of human trichinellosis: the impact of new Trichinella species F Bruschi, K D Murrell ............................................................................................................................. Postgrad Med J 2002;78:15–22 Trichinellosis is a re-emerging zoonosis and more on anti-inflammatory drugs and antihelminthics clinical awareness is needed. In particular, the such as mebendazole and albendazole; the use of these drugs is now aided by greater clinical description of new Trichinella species such as T papuae experience with trichinellosis associated with the and T murrelli and the occurrence of human cases increased number of outbreaks. caused by T pseudospiralis, until very recently thought to The description of new Trichinella species, such as T murrelli and T papuae, as well as the occur only in animals, requires changes in our handling occurrence of outbreaks caused by species not of clinical trichinellosis, because existing knowledge is previously recognised as infective for humans, based mostly on cases due to classical T spiralis such as T pseudospiralis, now render the clinical picture of trichinellosis potentially more compli- infection. The aim of the present review is to integrate cated. Clinicians and particularly infectious dis- the experiences derived from different outbreaks around ease specialists should consider the issues dis- the world, caused by different Trichinella species, in cussed in this review when making a diagnosis and choosing treatment. order to provide a more comprehensive approach to diagnosis and treatment. SYSTEMATICS .......................................................................... Trichinellosis results from infection by a parasitic nematode belonging to the genus trichinella. -
Opsonin-Dependent Stimulation of Bovine Neutrophil Oxidative Metabolism by Brucella Abortus Peter C
Veterinary Microbiology and Preventive Medicine Veterinary Microbiology and Preventive Medicine Publications 2-1988 Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus Peter C. Canning U.S. Department of Agriculture Billy L. Deyoe U.S. Department of Agriculture James A. Roth Iowa State University, [email protected] Follow this and additional works at: https://lib.dr.iastate.edu/vmpm_pubs Part of the Veterinary Microbiology and Immunobiology Commons, Veterinary Preventive Medicine, Epidemiology, and Public Health Commons, and the Veterinary Toxicology and Pharmacology Commons The ompc lete bibliographic information for this item can be found at https://lib.dr.iastate.edu/ vmpm_pubs/190. For information on how to cite this item, please visit http://lib.dr.iastate.edu/ howtocite.html. This Article is brought to you for free and open access by the Veterinary Microbiology and Preventive Medicine at Iowa State University Digital Repository. It has been accepted for inclusion in Veterinary Microbiology and Preventive Medicine Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus Abstract Nonopsonized Brucella abortus and bacteria treated with fresh antiserum, heat-inactivated antiserum, or normal bovine serum were evaluated for their ability to stimulate production of superoxide anion and myeloperoxidasemediated iodination by neutrophils from cattle. Brucella abortus opsonized with fresh antiserum or beat-inactivated antiserum stimulated production of approximately 3 nmol of 0 2 -/106 neutrophils/30 min. Similarly treated bacteria also stimulated the binding of approximately 4.3 nmol of Nal/ 107 neutrophils/h to protein.